Correspondence 0001193125-23-066254 from Cullinan Therapeutics, Inc. (CGEM) (CIK 0001789972) (CGEM)
Cullinan Therapeutics, Inc. (CGEM) (CIK 0001789972)
Date: March 9, 2023 · CIK: 0001789972 · Accession: 0001193125-23-066254
AI Filing Summary & Sentiment
File numbers found in text: 333-270384
Letter
CULLINAN ONCOLOGY, INC.
One Main Street, Suite 1350
Cambridge, MA 02142
March 9, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Jimmy McNamara
Re:
Cullinan Oncology, Inc.
Registration Statement on Form S-3 (File No. 333-270384)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cullinan Oncology, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on March 13, 2023, or as soon as possible thereafter. The Company hereby authorizes Thomas Danielski of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please call Thomas Danielski of Ropes & Gray LLP, counsel to the Company, at (617) 235-4961 as soon as the registration statement has been declared effective.
[Signature page follows]
Very truly yours,
CULLINAN ONCOLOGY, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP CULLINAN ONCOLOGY, INC. One Main Street, Suite 1350 Cambridge, MA 02142 March 9, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Jimmy McNamara Re: Cullinan Oncology, Inc. Registration Statement on Form S-3 (File No. 333-270384) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cullinan Oncology, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on March 13, 2023, or as soon as possible thereafter. The Company hereby authorizes Thomas Danielski of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Please call Thomas Danielski of Ropes & Gray LLP, counsel to the Company, at (617) 235-4961 as soon as the registration statement has been declared effective. [Signature page follows] Very truly yours, CULLINAN ONCOLOGY, INC. By: /s/ Jeffrey Trigilio Name: Jeffrey Trigilio Title: Chief Financial Officer [Signature Page to Acceleration Request]